Clinical Trials Browser

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00182702 2013-03-25

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2 Completed

37 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00021099 2013-01-24

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

Phase 2 Completed

45 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

Phase 2 Completed

102 enrolled 10 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00030108 2012-03-15

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Phase 1 Completed

30 enrolled

CNSGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Eosinophilic, Acute, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

BMS 247550 to Treat Kidney Cancer

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy